MXVHX
Price
$6.83
Change
-$0.04 (-0.58%)
Updated
Jun 25 closing price
Net Assets
1.65B
VIVAX
Price
$68.23
Change
-$0.39 (-0.57%)
Updated
Jun 25 closing price
Net Assets
188.77B
Interact to see
Advertisement

MXVHX vs VIVAX

Header iconMXVHX vs VIVAX Comparison
Open Charts MXVHX vs VIVAXBanner chart's image
Empower Large Cap Value Instl
Price$6.83
Change-$0.04 (-0.58%)
VolumeN/A
Net Assets1.65B
Vanguard Value Index I
Price$68.23
Change-$0.39 (-0.57%)
VolumeN/A
Net Assets188.77B
MXVHX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MXVHX vs. VIVAX commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXVHX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. MXVHX (1.65B). MXVHX pays higher dividends than VIVAX: MXVHX (2.53) vs VIVAX (2.16). MXVHX was incepted earlier than VIVAX: MXVHX (10 years) vs VIVAX (33 years). MXVHX (0.61) is less costly to investors than VIVAX (0.17). MXVHX is a more actively managed with annual turnover of: 31.00 vs. VIVAX (9.00). MXVHX has a lower initial minimum investment than VIVAX: MXVHX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 8.95 vs. MXVHX (-8.12). VIVAX return over 5 years is better than : 82.01 vs. MXVHX (27.03).
MXVHXVIVAXMXVHX / VIVAX
Total Expense Ratio0.610.17359%
Annual Report Gross Expense Ratio0.610.17359%
Fund Existence10 years33 years-
Gain YTD5.5303.903142%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B189B1%
Annual Yield % from dividends2.532.16117%
Returns for 1 year-8.128.95-91%
Returns for 3 years1.2331.744%
Returns for 5 years27.0382.0133%
Returns for 10 years-6.08107.55-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPX2.620.08
+3.15%
Compass Therapeutics
C81.141.78
+2.24%
Citigroup
VRCA0.600.01
+1.82%
Verrica Pharmaceuticals
BC56.490.22
+0.39%
Brunswick Corp
SGML4.55-0.06
-1.30%
Sigma Lithium Corp